This observation seemed to be connected to type 2 immunity since obese mice had significantly higher levels of IL-13 in the serum and an augmented expression of IL-13 receptor in colon tissue, which led authors to propose the involvement of this cytokine in the development of obesity-related CRC [106]. The gene discussed is IL13; the disease is colorectal carcinoma.